GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
6MSS | P11609 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
6MSS | P01887 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
3AZS | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Mannotriose | |
3AZT | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellotetraose | |
3AZR | Q9X273 | Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellobiose | |
5L6N | P00734 | Disulfated madanin-thrombin complex | |
5L6N | Q86FP9 | Disulfated madanin-thrombin complex | |
6XR8 | P0DTC2 | Distinct conformational states of SARS-CoV-2 spike protein | |
6XRA | P0DTC2 | Distinct conformational states of SARS-CoV-2 spike protein | |
7A92 | P0DTC2 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | |
7A92 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | |
7A91 | P0DTC2 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7A91 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R12 | P0DTC2 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R12 | Q9BYF1 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R11 | P0DTC2 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R11 | Q9BYF1 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R0Z | P0DTC2 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R0Z | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R10 | P0DTC2 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 | |
7R10 | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 | |
5CPS | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - maltotriose soak | |
5CQ1 | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - cycloamylose soak | |
5CPT | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - beta cyclodextrin soak | |
5CSU | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - acarviostatin soak | |
5CSY | Q9LV91 | Disproportionating enzyme 1 from Arabidopsis - acarbose soak | |
5NES | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5NES | 5NES | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5NEY | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5NEY | 5NEY | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5NF0 | A0A069Q9V4 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5NF0 | 5NF0 | Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa | |
5BQH | O14684 | Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain | |
5BQI | O14684 | Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain | |
5KOQ | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
5KOS | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
5KOT | P00797 | Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor | |
3PDF | P53634 | Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C | |
6ZJZ | Q9NR97 | Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity | |
4CZS | C0HJY1 | Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides | |
4CZS | 4CZS | Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides | |
4RCH | P35557 | Discovery of 2-Pyridyl Ureas as Glucokinase Activators | |
5K5E | P06276 | Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening | |
3IJ7 | P04746 | Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase | |
3IJ8 | P04746 | Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase | |
3IJ9 | P04746 | Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase | |
6EL4 | B9W4V6 | Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with veratryl alcohol | |
6EL0 | B9W4V6 | Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with styrene | |
6EKZ | B9W4V6 | Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with propranolol | |
6EKW | B9W4V6 | Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with naphthalene |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024